Collegium (COLL) Xtampza ER Sales More than Double Expectations - William Blair

Go back to Collegium (COLL) Xtampza ER Sales More than Double Expectations - William Blair

Collegium Pharma (COLL) Tops Q3 EPS by 29c

November 8, 2017 4:26 PM EST

Collegium Pharma (NASDAQ: COLL) reported Q3 EPS of ($0.45), $0.29 better than the analyst estimate of ($0.74).

For earnings history and earnings-related data on Collegium Pharma (COLL) click here.

... More